Letrozole

Product Description:
Letrozole is a potent antitumor agent known for its non-steroidal, selective inhibition of the aromatase enzyme. Widely prescribed in medicine for post-menopausal therapy in women and breast cancer treatment, it has also gained popularity among athletes for its strong anti-estrogenic properties and ability to enhance muscle definition. With effects up to five times stronger than Anastroloze (Arimidex), Letrozole effectively mitigates adverse reactions from anabolic steroid use by suppressing estrogen levels in the body, offering comprehensive protection against aromatization.

Effects:
Athletes utilizing Letrozole can achieve nearly complete suppression of estrogen levels, providing robust protection against aromatization.

Side-Effects:
Common side effects associated with Letrozole include skin rash, nausea, abdominal pain, fatigue, dizziness, headache, elevated Low-density cholesterol levels, and liver enzyme levels.

Protection:
Prior to Letrozole use, a preliminary blood test is recommended to gauge its effectiveness in reducing estradiol levels. Letrozole significantly reduces estradiol levels, enhancing cycle efficacy, and is typically incorporated into post-cycle therapy (PCT) as an anti-estrogenic agent.

Stacking:
While Letrozole is most effective during PCT, it can also be stacked with clomiphene or other steroids during the cycle to optimize results.

Download Letrozole Product Test

verify our products